Cefpodoxime 200 mg +Oflaxacin 200 mg tab

ITC-HSN3004

50.00  / UNT (Unit)
45.00  / UNT (Unit)

Inclusive of all taxes

You Save: 5. Discount: 10%

  • Product is not available

Availability : In Stock

Minimum Order Quantity100000

Accept Small Orders No

Country Of Origin : India

 Flange Pharmaceuticals Private Limited, a leading player in the Indian pharmaceutical industry, has announced the launch of Ofpod O, a cutting-edge antibiotic combination tablet containing Cefpodoxime 200 mg and Ofloxacin 200 mg. This innovative formulation is poised to revolutionize the treatment of various bacterial infections.


Ofpod O is meticulously crafted to address the growing challenge of antibiotic resistance, a global health concern. The synergistic combination of Cefpodoxime and Ofloxacin provides broad-spectrum antibacterial activity, effectively targeting a wide range of pathogens.

  • Additional Information

    Potent Combination: The unique blend of Cefpodoxime and Ofloxacin ensures optimal efficacy against a wide spectrum of bacteria.

    Rapid Action: Designed for quick absorption and rapid onset of action, providing faster relief from infection symptoms.

    Convenient Dosage: The tablet formulation offers a convenient and easy-to-administer dosage for patients.

             


    With its strong research and development capabilities, Flange Pharmaceuticals is dedicated to delivering high-quality, affordable medicines to patients across India. The company is confident that Ofpod O will make a significant contribution to improving patient outcomes and public health.

  • Reviews ()

    Write a Review